Clinical Trial Update: Transfusion-Transmitted Cytomegalovirus Prevention in Neonates [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating prevention of transfusion-transmitted cytomegalovirus infection in neonates has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Blood Transfusion, Cytomegalovirus Infections | Phase 3 | Status: COMPLETED